These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 23129563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H, Bowser R.
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA, An J, Hood BL, Conrads TP, Bowser RP.
    J Proteome Res; 2015 Nov 06; 14(11):4486-501. PubMed ID: 26401960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
    Barschke P, Oeckl P, Steinacker P, Ludolph A, Otto M.
    Expert Rev Proteomics; 2017 Sep 06; 14(9):769-777. PubMed ID: 28799854
    [Abstract] [Full Text] [Related]

  • 9. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).
    Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H.
    Neurosci Lett; 2010 Jan 01; 468(1):23-7. PubMed ID: 19853641
    [Abstract] [Full Text] [Related]

  • 10. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
    Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H.
    J Proteome Res; 2007 Dec 01; 6(12):4549-55. PubMed ID: 17970587
    [Abstract] [Full Text] [Related]

  • 11. Amyotrophic lateral sclerosis--the tools of the trait.
    Lederer CW, Santama N.
    Biotechnol J; 2007 May 01; 2(5):608-21. PubMed ID: 17345579
    [Abstract] [Full Text] [Related]

  • 12. Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?
    Moreno-Martinez L, Calvo AC, Muñoz MJ, Osta R.
    Int J Mol Sci; 2019 Jun 05; 20(11):. PubMed ID: 31195629
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, Tumani H.
    Neurology; 2010 Mar 23; 74(12):982-7. PubMed ID: 20308682
    [Abstract] [Full Text] [Related]

  • 15. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP.
    Neurology; 2009 Jun 02; 72(22):1948-52. PubMed ID: 19487653
    [Abstract] [Full Text] [Related]

  • 16. Role of proteomics in the discovery of autism biomarkers.
    Al-Ayadhi L, Halepoto DM.
    J Coll Physicians Surg Pak; 2013 Feb 02; 23(2):137-43. PubMed ID: 23374519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proteomic analysis of muscle affected by motor neuron degeneration: the wobbler mouse model of amyotrophic lateral sclerosis.
    Staunton L, Jockusch H, Ohlendieck K.
    Biochem Biophys Res Commun; 2011 Mar 25; 406(4):595-600. PubMed ID: 21354103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.